Marseille Quincé is a long established company with offices in Hong Kong, Thailand and Cambodia, with patents in stem cell and recombinant proteins production and application on intra-articular injection, medical gauze and bandage for the consumer market.
Marseille Quincé has been developing cutting-edge applications in biotechnology, such as development of recombinant proteins, stem cells, and exosome, using the power of stem cells and plasma cytokine derived precursors to communicate and catalyze healing results down to the nucleus of the cell.
Marseille Quincé is at the leading edge of research and treatments that have catalyzed a Renaissance in the “art of cellular medicine.” We believe that the use of Marseille Quincé-Cytokines is a quantum leap in our clinical practice. We have been using Marseille Quincé-Cytokines to enhance our results with cell therapy for the last 12 years, both in research and in clinical practice. We have been developing and practicing Marseille Quincé-Cytokines therapy as a topical treatment, used for skin and hair rejuvenation, medical gauze and bandage for wound healing, intra-articular injection for joint cartilage regeneration, as well as an intravenous injection for therapeutic use in cellular regeneration.
Marseille Quincé has pioneered and achieved new dynamics in cell therapies that have documented the reversal of progression of chronic disease, arthritis and accelerated healing for acute and chronic wounds.
